Australia, Sept. 16 -- DEKA Research & Development Corp., owns the trademark (2407831) for 'S SEQUEL' and '2 CURVED STRIPES FORM LTR S' till Aug. 18, 2033.
Status: protected:
Registered/protected
Classes: 5 [Infusion cartridges sold pre-filled with medication for medical use in the field of cardiovascular disease, diabetes, asthma, kidney disease, and cancer; adhesive overlays in the nature of adhesive medical tape and adhesive bandages for use with infusion pumps and associated devices, all of the foregoing for use in connection with a device for the delivery of therapeutic agents for the treatment of disease, and none of the foregoing for use in connection with parasitic preparations.], 9 [Software as a Medical Device (SaMD), downloadable, for predicting blood analyte levels and adjusting infusion pump settings based on personalized data for use in connection with a device for the delivery of therapeutic agents for the treatment of disease; downloadable educational mobile applications featuring information and instruction on managing, treating and living with chronic disease; batteries; battery chargers.], 10 [Medical devices, namely, infusion and injection devices for administering therapeutic agents for the treatment of disease; medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time for the treatment of disease; medical apparatus for monitoring blood analyte levels for use in connection with a device for the delivery of therapeutic agents for the treatment of disease; wearable subcutaneous devices for the delivery of therapeutic agents for the treatment of disease, sold empty in the nature of injectors; on-body medical fluid injectors for the delivery of therapeutic agents for the treatment of disease; chronic disease management devices, in the nature of medical sensors for use in connection with a device for the delivery of therapeutic agents for the treatment of disease that are implanted or inserted into the human body used to continuously monitor the concentration of analytes in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices; medical infusion sets comprised of infusion tubing, infusion needles, needle guards, connectors, attachment clips, and accessories therefor, all used for the delivery of therapeutic agents for the treatment of disease.], 35 [Administration of a trade-in and upgrade program for drug delivery and chronic disease management devices; mail order, online and telephone pharmacy retail services featuring chronic disease management supplies medications, drugs and other prescriptions.], 41 [Educational services, namely, creating and developing web-based and in person classes, seminars, workshops and programs in the field of managing and living with chronic disease; personalized training and coaching in the use of monitoring devices and infusion pumps in the treatment of chronic disease; training of healthcare providers in chronic disease treatment and the use of infusion pumps and infusion sets.], 42 [Software-as-a-service (SaaS) featuring software for use in the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data obtained from medical sensors that are implanted or inserted into the human body; hosting an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to managing chronic disease, medication and analyte levels for predicting blood analyte levels and adjusting infusion pump settings based on personalized data for use in connection with a device for the delivery of therapeutic agents for the treatment of disease.] and 44 [Interactive medical monitoring and alert services for reminding infusion pump users of medicinal dosage for medical treatment purposes in the nature of monitoring and managing chronic disease; providing medical information to infusion pump users for use in connection with a device for the delivery of therapeutic agents for the treatment of disease in the form of reports in the field of chronic disease management; providing medical information for consumers and healthcare practitioners via online databases; medical consultation services, namely, patient ambassador program to communicate medical information to people with chronic disease, all of the foregoing related to use of a device for the delivery of therapeutic agents for the treatment of disease.]
Type of Mark: Figurative
Date of Acceptance: July 7
Registration Advertised: Sept. 15
For further details contact Henry Hughes IP Ltd. and Mark E. Tetreault.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2407831.
Disclaimer: Curated by HT Syndication.
